Share

July 2019; 6 (4) EditorialOpen Access

Contribution of polymorphonuclear neutrophils in the blood periphery to ischemic brain injury

Dirk M. Hermann, Matthias Gunzer
First published May 15, 2019, DOI: https://doi.org/10.1212/NXI.0000000000000570
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
597

Share

Article Information

vol. 6 no. 4 e570
DOI: 
https://doi.org/10.1212/NXI.0000000000000570
PubMed: 
31355306
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • First Published May 15, 2019.
Copyright & Usage: 
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Dirk M. Hermann, MD and
    2. Matthias Gunzer, PhD
  1. Dirk M. Hermann, MD and
    2. Scientific Advisory Boards:

    1. Commercial: Servier (Suresnes, France)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate editor Frontiers of Cellular Neurosciences Editorial board member Basic Research in Cardiology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. German Research Foundation (HE-3173/11-1) 2018-now

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Matthias Gunzer, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Speaker honorarium, Hexal (2) Speaker honorarium Mundipharma

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (D.M.H.), University Hospital Essen, University of Duisburg-Essen; and Institute of Experimental Immunology and Imaging (M.G.), University Hospital Essen, University of Duisburg-Essen, Germany.
  1. Correspondence
    Dr. Hermann dirk.hermann{at}uk-essen.de or Dr. Gunzer matthias.gunzer{at}uk-essen.de

Article usage

Article usage: May 2019 to October 2023

AbstractFullPdfSource
May 2019812052Highwire
Jun 2019126735Highwire
Jul 2019414131Highwire
Aug 201943413Highwire
Sep 201923213Highwire
Oct 20190379Highwire
Nov 20190318Highwire
Dec 201902012Highwire
Jan 20200517Highwire
Feb 20200266Highwire
Mar 202003317Highwire
Apr 20200314Highwire
May 2020017122Highwire
Jun 202001511Highwire
Jul 20200405Highwire
Aug 202001515Highwire
Sep 202012312Highwire
Oct 20200258Highwire
Nov 202011710Highwire
Dec 20201152Highwire
Jan 202121416Highwire
Feb 2021084Highwire
Mar 202101314Highwire
Apr 20211109Highwire
May 202112317Highwire
Jun 20210155Highwire
Jul 20211208Highwire
Aug 2021056Highwire
Sep 2021165Highwire
Oct 202101616Highwire
Nov 20210914Highwire
Dec 202102815Highwire
Jan 20220174Highwire
Feb 202212013Highwire
Mar 20220134Highwire
Apr 2022291Highwire
May 202201910Highwire
Jun 20220169Highwire
Jul 20220140Highwire
Aug 20220173Highwire
Sep 202202516Highwire
Oct 202202410Highwire
Nov 202204421Highwire
Dec 20221185Highwire
Jan 202303411Highwire
Feb 20230197Highwire
Mar 20230156Highwire
Apr 2023088Highwire
May 20230148Highwire
Jun 202301010Highwire
Jul 2023058Highwire
Aug 2023074Highwire
Sep 202301010Highwire
Oct 20230148Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles